Created
February 18, 2026 23:42
-
-
Save ericnovik/08acd724328bdaf8a62b561afb8b7e89 to your computer and use it in GitHub Desktop.
This file contains hidden or bidirectional Unicode text that may be interpreted or compiled differently than what appears below. To review, open the file in an editor that reveals hidden Unicode characters.
Learn more about bidirectional Unicode characters
| Study | End_Point | Intervention_Events_n | Intervention_Events_N | Control_Events_n | Control_Events_N | HR | CI_Low | CI_High | |
|---|---|---|---|---|---|---|---|---|---|
| APACHE-AF | Any stroke or cardiovascular death | 13 | 50 | 12 | 51 | 1.07 | 0.49 | 2.34 | |
| SOSTART | Any stroke or cardiovascular death | 12 | 100 | 23 | 101 | 0.54 | 0.27 | 1.09 | |
| NASPAF-ICH | Any stroke or cardiovascular death | 0 | 21 | 1 | 9 | 0.12 | 0 | 11.2 | |
| ELDERCARE-AF | Any stroke or cardiovascular death | 4 | 41 | 7 | 39 | 0.52 | 0.15 | 1.78 | |
| Overall | Any stroke or cardiovascular death | 0.68 | 0.42 | 1.1 | |||||
| APACHE-AF | Ischaemic major adverse cardiovascular events | 6 | 50 | 11 | 51 | 0.46 | 0.17 | 1.25 | |
| SOSTART | Ischaemic major adverse cardiovascular events | 3 | 100 | 21 | 101 | 0.15 | 0.04 | 0.49 | |
| NASPAF-ICH | Ischaemic major adverse cardiovascular events | 0 | 21 | 1 | 9 | 0.12 | 0 | 11.2 | |
| ELDERCARE-AF | Ischaemic major adverse cardiovascular events | 0 | 41 | 5 | 39 | 0.09 | 0 | 2.12 | |
| Overall | Ischaemic major adverse cardiovascular events | 0.27 | 0.13 | 0.56 | |||||
| APACHE-AF | Haemorrhagic major adverse cardiovascular events | 6 | 50 | 3 | 51 | 2.14 | 0.53 | 8.57 | |
| SOSTART | Haemorrhagic major adverse cardiovascular events | 8 | 100 | 4 | 101 | 2.18 | 0.66 | 7.24 | |
| NASPAF-ICH | Haemorrhagic major adverse cardiovascular events | 0 | 21 | 1 | 9 | 0.13 | 0 | 12.32 | |
| ELDERCARE-AF | Haemorrhagic major adverse cardiovascular events | 1 | 41 | 1 | 39 | 0.89 | 0.06 | 14.25 | |
| Overall | Haemorrhagic major adverse cardiovascular events | 1.8 | 0.77 | 4.21 | |||||
| APACHE-AF | Death from any cause | 9 | 50 | 11 | 51 | 0.79 | 0.33 | 1.9 | |
| SOSTART | Death from any cause | 22 | 100 | 11 | 101 | 2.26 | 1.09 | 4.66 | |
| NASPAF-ICH | Death from any cause | 1 | 21 | 2 | 9 | 0.19 | 0.02 | 2.09 | |
| ELDERCARE-AF | Death from any cause | 6 | 41 | 5 | 39 | 1.11 | 0.34 | 3.66 | |
| Overall | Death from any cause | 1.29 | 0.78 | 2.11 |
Author
Sign up for free
to join this conversation on GitHub.
Already have an account?
Sign in to comment
Al-Shahi Salman, R., Stephen, J., Tierney, J. F., Lewis, S. C., Newby, D. E., Parry-Jones, A. R., White, P. M., Connolly, S. J., Benavente, O. R., Dowlatshahi, D., Cordonnier, C., Viscoli, C. M., Sheth, K. N., Kamel, H., Veltkamp, R., Larsen, K. T., Hofmeijer, J., Kerkhoff, H., Schreuder, F. H. B. M., … Collaboration of Controlled Randomised Trials of Long-Term Oral Antithrombotic Agents After Spontaneous Intracranial Haemorrhage (COCROACH). (2023). Effects of oral anticoagulation in people with atrial fibrillation after spontaneous intracranial haemorrhage (COCROACH): prospective, individual participant data meta-analysis of randomised trials. Lancet Neurology, 22(12), 1140–1149.